Related Experiment Video
Updated: Sep 29, 2025

Using 2-Photon Microscopy to Quantify the Effects of Chronic Unilateral Ureteral Obstruction on Glomerular Processes
Published on: March 4, 2022
The Interplay between Uremic Toxins and Albumin, Membrane Transporters and Drug Interaction
Regiane Stafim da Cunha1, Carolina Amaral Bueno Azevedo1, Carlos Alexandre Falconi2
1Experimental Nephrology Laboratory, Basic Pathology Department, Universidade Federal do Paraná, Curitiba 81531-980, Brazil.
Abstract:
Uremic toxins are a heterogeneous group of molecules that accumulate in the body due to the progression of chronic kidney disease (CKD). These toxins are associated with kidney dysfunction and the development of comorbidities in patients with CKD, being only partially eliminated by dialysis therapies. Importantly, drugs used in clinical treatments may affect the levels of uremic toxins, their tissue disposition, and even their elimination through the interaction of both with proteins such as albumin and cell membrane transporters. In this context, protein-bound uremic toxins (PBUTs) are highlighted for their high affinity for albumin, the most abundant serum protein with multiple binding sites and an ability to interact with drugs. Membrane transporters mediate the cellular influx and efflux of various uremic toxins, which may also compete with drugs as substrates, and both may alter transporter activity or expression. Therefore, this review explores the interaction mechanisms between uremic toxins and albumin, as well as membrane transporters, considering their potential relationship with drugs used in clinical practice.
Insights
Uremic toxins, accumulating in chronic kidney disease (CKD), interact with albumin and transporters, affecting drug efficacy. Understanding these interactions is crucial for managing CKD comorbidities and treatment.
Area of Science:
- Nephrology
- Pharmacology
- Biochemistry
Background:
- Uremic toxins accumulate in chronic kidney disease (CKD), contributing to kidney dysfunction and comorbidities.
- Dialysis partially removes these toxins, but drug interactions complicate their management.
- Protein-bound uremic toxins (PBUTs) and membrane transporter substrates are key areas of concern.
Purpose of the Study:
- To explore interaction mechanisms between uremic toxins, albumin, and membrane transporters.
- To investigate the relationship between these interactions and drugs used in clinical practice.
- To provide insights into managing drug therapy in CKD patients.
Main Methods:
- Literature review of studies on uremic toxin-protein binding.
- Analysis of research on uremic toxin-transporter interactions.
- Examination of drug-toxin-protein/transporter interplay.
Main Results:
- Uremic toxins exhibit high affinity for albumin, influencing drug binding and disposition.
- Membrane transporters mediate toxin transport, with potential for drug competition and altered activity.
- Drug interactions with albumin and transporters can modify uremic toxin levels and effects.
Conclusions:
- Interactions between uremic toxins, albumin, and transporters significantly impact drug therapy in CKD.
- Understanding these mechanisms is essential for optimizing treatment strategies and patient outcomes.
- Further research is needed to fully elucidate these complex relationships.
More Related Videos
Related Concept Videos
Drug Elimination by Renal Route: Tubular Secretion
Factors Affecting Protein-Drug Binding: Drug Interactions
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Drug Distribution: Plasma Protein Binding
Drug Elimination by Renal Route: Tubular Reabsorption
Pore Transport and Ion-Pair Transport
Pore transport, also known as convective transport, is a process where small molecules like urea, water, and sugars rapidly cross cell membranes as though there were channels or pores in the membrane. Although direct microscopic evidence is limited but the concept of pores or channels is widely accepted based on physiological evidence. Despite the lack of direct...
Factors Affecting Renal Clearance: Drug Distribution and Drug Interactions
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...

